What is the official ID of this bill?

The official print number for this legislation is SRES 255.

When did the legislative process begin?

The process officially started on 2023-06-15.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/bills/sres255/BILLS-118sres255is.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Who is the primary sponsor?

The primary sponsor is Sen. Booker, Cory A. [D-NJ].

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Analysis and Potential Impact of SRES 255

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Senate Supports Sickle Cell Awareness Day and Equitable Access to Gene Therapy.

Q: What are the main provisions?

Key points include: Pushes to eliminate financial barriers in Medicare and Medicaid systems, ensuring vulnerable patients can access innovative treatments like gene and cell therapies for SCD. Calls for the formation of a federal interagency group to address equitable access to therapies and combat systemic bias faced by the SCD population in healthcare. Stresses the ongoing need for increased research, early detection screenings, and preventative care programs globally and domestically.

The US Senate supports designating June 19 as World Sickle Cell Awareness Day to boost public knowledge and research into cures. The resolution calls for immediate action to improve health outcomes by ensuring equitable access to new treatments. Crucially, it urges the removal of financial barriers within Medicare and Medicaid for vulnerable patients needing innovative cell and gene therapies.

Key points

Pushes to eliminate financial barriers in Medicare and Medicaid systems, ensuring vulnerable patients can access innovative treatments like gene and cell therapies for SCD.

Calls for the formation of a federal interagency group to address equitable access to therapies and combat systemic bias faced by the SCD population in healthcare.

Stresses the ongoing need for increased research, early detection screenings, and preventative care programs globally and domestically.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

A resolution expressing support for the designation of June 19, 2023, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

Print number: SRES 255

Sponsor: Sen. Booker, Cory A. [D-NJ]

Process start date: 2023-06-15

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-09-2025

Source data: api.congress.gov

AI work logs for this document launch

Senate Supports Sickle Cell Awareness Day and Equitable Access to Gene Therapy.

Key Questions about Senate Supports Sickle Cell Awareness Day and Equitable Access to Gene Therapy.